01 16BOEHRINGER INGELHEIM
01 167713938
01 16Y
01 16Y
01 162027-04-15
Patent Expiration Date : 2027-04-15
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204629
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208658
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206073
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212614
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206111
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208658
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206111
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208658
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206073
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
Patent Expiration Date : 2027-04-15
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7713938
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206111
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-15
